These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry. McDonald SP; Russ GR; Kerr PG; Collins JF; Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029 [TBL] [Abstract][Full Text] [Related]
6. Low socio-economic status adversely effects dialysis survival in Australia. Krishnasamy R; Gray NA Nephrology (Carlton); 2018 May; 23(5):453-460. PubMed ID: 28383177 [TBL] [Abstract][Full Text] [Related]
7. Estimating the total incidence of kidney failure in Australia including individuals who are not treated by dialysis or transplantation. Sparke C; Moon L; Green F; Mathew T; Cass A; Chadban S; Chapman J; Hoy W; McDonald S Am J Kidney Dis; 2013 Mar; 61(3):413-9. PubMed ID: 23177731 [TBL] [Abstract][Full Text] [Related]
8. End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases. Tang W; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; de Zoysa JR; Johnson DW Nephrol Dial Transplant; 2013 Feb; 28(2):455-61. PubMed ID: 23182810 [TBL] [Abstract][Full Text] [Related]
9. Medical practice patterns and socio-economic factors may explain geographical variation of end-stage renal disease incidence. Couchoud C; Guihenneuc C; Bayer F; Lemaitre V; Brunet P; Stengel B; Nephrol Dial Transplant; 2012 Jun; 27(6):2312-22. PubMed ID: 22121236 [TBL] [Abstract][Full Text] [Related]
10. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006. Kramer A; Stel V; Zoccali C; Heaf J; Ansell D; Grönhagen-Riska C; Leivestad T; Simpson K; Pálsson R; Postorino M; Jager K; Nephrol Dial Transplant; 2009 Dec; 24(12):3557-66. PubMed ID: 19820003 [TBL] [Abstract][Full Text] [Related]
11. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005). Villar E; Chang SH; McDonald SP Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610 [TBL] [Abstract][Full Text] [Related]
12. Nationwide survey of adolescents and young adults with end-stage kidney disease. Ritchie AG; Clayton PA; Mackie FE; Kennedy SE Nephrology (Carlton); 2012 Aug; 17(6):539-44. PubMed ID: 22489755 [TBL] [Abstract][Full Text] [Related]
13. Validity of registry data: agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting). Webster AC; Supramaniam R; O'Connell DL; Chapman JR; Craig JC Nephrology (Carlton); 2010 Jun; 15(4):491-501. PubMed ID: 20609104 [TBL] [Abstract][Full Text] [Related]
14. Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry. Disney AP Am J Kidney Dis; 1995 Jan; 25(1):165-75. PubMed ID: 7810521 [TBL] [Abstract][Full Text] [Related]
16. Renal replacement therapy associated with lithium nephrotoxicity in New Zealand. Wells JE; Cross NB; Savage RL; Parkin L; Horsburgh S; Richardson AK N Z Med J; 2015 Nov; 128(1425):77-83. PubMed ID: 26905990 [TBL] [Abstract][Full Text] [Related]
17. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002. ; Stewart JH; McCredie MR; Williams SM Nephrol Dial Transplant; 2006 Aug; 21(8):2178-83. PubMed ID: 16595584 [TBL] [Abstract][Full Text] [Related]
18. Trends in hemodialysis vascular access from the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) 2000 to 2005. Moist LM; Chang SH; Polkinghorne KR; McDonald SP; Am J Kidney Dis; 2007 Oct; 50(4):612-21. PubMed ID: 17900461 [TBL] [Abstract][Full Text] [Related]
19. How much of the regional variation in RRT incidence rates within the UK is explained by the health needs of the general population? Castledine CI; Gilg JA; Rogers C; Ben-Shlomo Y; Caskey FJ Nephrol Dial Transplant; 2012 Oct; 27(10):3943-50. PubMed ID: 22778180 [TBL] [Abstract][Full Text] [Related]
20. Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in Australia. Stewart JH; McCredie MR; Williams SM; McDonald SP Nephrology (Carlton); 2004 Aug; 9(4):238-46. PubMed ID: 15363056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]